Ajooni Biotech Limited

NSE AJOONI.NS

Ajooni Biotech Limited EBITDA for the year ending March 31, 2024: USD 530.78 K

Ajooni Biotech Limited EBITDA is USD 530.78 K for the year ending March 31, 2024, a 42.56% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Ajooni Biotech Limited EBITDA for the year ending March 31, 2023 was USD 372.31 K, a -9.16% change year over year.
Ajooni Biotech Limited EBITDA for the year ending March 31, 2022 was USD 409.84 K, a 90.30% change year over year.
Ajooni Biotech Limited EBITDA for the year ending March 31, 2021 was USD 215.36 K, a 30.07% change year over year.
Ajooni Biotech Limited EBITDA for the year ending March 31, 2020 was USD 165.58 K, a 52.28% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NSE: AJOONI.NS

Ajooni Biotech Limited

CEO	Mr. Gursimran Singh
IPO Date	Jan. 2, 2018
Location	India
Headquarters	D-118, Industrial Area
Employees	109
Sector	Consumer Staples
Industries Agriculture Biotechnology Pet Food

Description

Ajooni Biotech Limited manufactures and sells animal feed in India. The company offers cattle feeds and feed supplements. Ajooni Biotech Limited was incorporated in 2010 and is based in Mohali, India.

Key trends

Past 5 years